Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-Adhesion Product for Intraperitoneal Adhesions
NCT00512356Phase 2Completed
- Sponsor
- Baxter
- Start
- Dec 2000
- Primary completion
- Feb 2003
- Modality
- Biologic (Biologic)
- Countries
- 3
01
Overview
Phase 2, randomised, single-blind trial of Anti-Adhesion Product in abdominal adhesions (2 arms), sponsored by Baxter. Primary endpoint: Incidence of adhesions around the rectal stump and/or incision line at 8 months. Started Dec 2000; status: completed.
02
Drugs
Anti-Adhesion Product
03
Conditions
abdominal adhesions
Beyond the preview
Go deeper on NCT00512356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00512356.